No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
438 |
4. Check minimum number of eventsNone |
438 |
5. Include endpointsNone |
438 |
6. Filter based on genotype QC (FinnGen only) |
438 |
Control definitions (FinnGen only)
- Control exclude
- G6_AUTONOM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G90
- Name in latin
- Syndroma Horner
Similar endpoints
↥List of similar endpoints to
Horner syndrome
based on the number of shared cases.
Similar with more cases:
- Autonomic disorders
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2743 | 1372 | 1366 |
| Only index persons | 2515 | 1258 | 1257 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 52.54 | 54.09 | 50.94 |
| Only index persons | 52.78 | 54.46 | 51.10 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 438 | 242 | 196 |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | 0.09 |
| Median age at first event (years) | 55.53 | 55.55 | 55.49 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 401
- Matched controls
- 4010
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G90.2
ICD-10 Finland
Horner syndrome
+∞
323.0
394
*
H02.4
ICD-10 Finland
Ptosis of eyelid
13.6
34.0
60
51
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
9.3
29.2
63
79
H57.0
ICD-10 Finland
Anomalies of pupillary function
59.7
28.6
33
6
I67.0
ICD-10 Finland
Dissection of cerebral arteries, nonruptured
96.3
25.0
27
*
AA1AD
NOMESCO Finland
CT of head and brain
3.4
24.7
148
582
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
21.0
222
1239
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
14.1
20.6
35
27
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.8
19.1
67
160
PA6CG
NOMESCO Finland
Extensive MRI examination of neck vasculature with high intensity magnet
30.0
15.3
20
7
G44.0
ICD-10 Finland
Cluster headache syndrome
21.1
15.3
22
11
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.9
13.6
58
166
XCK00
NOMESCO Finland
Perimetry
4.3
13.0
49
125
XCK10
NOMESCO Finland
Photography of fundus of eye
3.4
12.6
63
206
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
8.3
11.5
25
32
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
16.1
10.9
17
11
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.6
10.6
83
363
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.8
9.8
27
49
B01AA03
ATC
warfarin; systemic
2.3
9.4
92
451
N03AX16
ATC
pregabalin; oral
2.2
9.2
114
624
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
19.1
9.0
13
7
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
19.1
9.0
13
7
35800
ICD-8 Finland
Disease of peripheral autonomic nervous system, Syndroma Horner
+∞
8.4
8
*
R51.80
ICD-10 Finland
Headache
2.4
8.2
70
319
N06AX21
ATC
duloxetine; oral
2.8
8.2
54
210
TAB00
NOMESCO Finland
Lumbar puncture
4.3
8.2
29
71
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.5
7.6
35
108
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
9.1
7.6
15
17
N02AX02
ATC
tramadol; systemic, rectal
1.8
7.6
182
1259
WX002
NOMESCO Finland
Sedation and analgesia
2.1
7.5
92
497
PA6AD
NOMESCO Finland
CT of neck arteries
7.9
7.5
16
21
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.4
7.4
35
110
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.6
7.4
54
227
PA7BD
NOMESCO Finland
CT angiography of neck and brain
7.5
7.3
16
22
Q13.2
ICD-10 Finland
Other congenital malformations of iris
30.6
7.2
9
*
C08DA01
ATC
verapamil; systemic
3.8
7.1
29
81
R42
ICD-10 Finland
Dizziness and giddiness
2.1
7.0
92
506
N02BE01
ATC
paracetamol; systemic, rectal
2.0
6.7
340
2943
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
12.5
6.6
11
9
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.4
6.5
54
242
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
4.8
6.5
20
43
CBJ41
NOMESCO Finland
Shortening of superior tarsal muscle (Müller's muscle)
70.9
6.4
7
*
ZXA10
NOMESCO Finland
Bilateral
2.1
6.4
81
440
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
11.3
6.3
11
10
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.1
6.3
33
113
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.1
6.3
32
108
WX110
NOMESCO Finland
Local anesthesy
1.7
6.1
269
2181
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.2
6.0
29
94
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3032080) INR in Blood by Coagulation assay
224
1396
2.24
15.21
8.1
8.6
inr
1.3
1.2
0.31
57
420
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
239
1584
2.12
13.26
6.9
6.2
mmol/l
1.2
1.2
0.95
220
1445
(42870588) Differential panel, method unspecified - Blood
185
1160
2.03
11.44
6.7
5.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
174
1070
2.04
11.34
2.4
2.0
u/l
186.8
268.5
0.57
164
1007
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
248
1729
2.00
11.30
8.6
7.0
mmol/l
1.2
1.2
0.08
206
1467
(3013826) Glucose [Moles/volume] in Serum or Plasma
286
2102
2.04
11.15
5.8
4.9
mmol/l
6.5
6.7
0.67
274
1957
(3033658) Prothrombin time (PT) actual/Normal
148
882
2.02
10.34
5.0
3.7
%
91.3
91.6
0.07
148
865
(3002030) Lymphocytes/100 leukocytes in Blood
242
1723
1.90
9.84
7.3
5.8
%
26.2
28.1
2.05
227
1614
(3013115) Eosinophils [#/volume] in Blood
255
1851
1.90
9.72
6.8
5.9
e9/l
0.2
0.2
0.31
229
1637
(3019069) Monocytes/100 leukocytes in Blood
235
1685
1.85
9.07
7.5
6.0
%
8.8
8.6
0.56
223
1587
(3006504) Eosinophils/100 leukocytes in Blood
234
1677
1.85
9.04
7.2
5.7
%
3.0
2.9
0.24
220
1566
(3001604) Monocytes [#/volume] in Blood
245
1786
1.84
8.91
6.8
5.6
e9/l
0.6
0.6
2.25
213
1553
(3019198) Lymphocytes [#/volume] in Blood
250
1838
1.84
8.80
6.7
5.6
e9/l
1.8
1.9
1.06
224
1632
(3022096) Basophils/100 leukocytes in Blood
227
1622
1.83
8.76
7.3
5.7
%
0.7
0.7
0.24
216
1520
(3018010) Neutrophils/100 leukocytes in Blood
236
1709
1.83
8.69
7.2
5.6
%
58.3
56.9
1.02
223
1612
(3006315) Basophils [#/volume] in Blood
245
1797
1.82
8.62
6.8
5.6
e9/l
0.0
0.0
0.27
215
1563
(3013650) Neutrophils [#/volume] in Blood by Automated count
271
2082
1.79
7.85
9.8
9.0
e9/l
4.5
4.0
1.87
240
1834
(3013707) Erythrocyte sedimentation rate by Westergren method
327
2673
1.88
7.57
5.5
4.1
mm/h
12.7
11.7
0.45
312
2463
(3024561) Albumin [Mass/volume] in Serum or Plasma
208
1499
1.74
7.38
6.2
4.8
g/l
35.2
35.7
0.68
191
1393
(3018418) pH of Serum or Plasma
160
1075
1.77
7.23
5.0
4.0
ph
7.4
7.4
2.65
35
206
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
133
855
1.80
6.93
2.4
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
144
948
1.77
6.92
4.3
4.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
380
3302
2.14
6.90
6.1
4.6
mu/l
1.8
2.2
0.59
354
3017
(40758558) Short blood count panel - Blood
135
875
1.78
6.83
7.1
6.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
332
2768
1.82
6.70
10.2
7.6
u/l
81.9
78.0
0.55
314
2595
(3023103) Potassium [Moles/volume] in Serum or Plasma
411
3714
2.73
6.40
22.2
15.8
mmol/l
4.0
4.0
1.04
402
3608
(3019550) Sodium [Moles/volume] in Serum or Plasma
410
3703
2.68
6.35
22.1
15.7
mmol/l
139.6
139.7
0.18
402
3600
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
109
680
1.80
6.20
4.3
3.7
ng/l
95.5
322.3
1.63
85
518
(40767503) Oxygen content in Capillary blood by calculation
22
68
3.35
6.08
2.0
2.4
%
17.2
16.2
—
10
30
(3015377) Calcium [Moles/volume] in Serum or Plasma
166
1175
1.66
5.96
3.4
3.4
mmol/l
2.3
2.4
1.11
145
1038
(3003396) Base excess in Arterial blood by calculation
71
395
1.95
5.74
6.3
9.2
mmol/l
0.8
1.2
0.30
57
323
(3037467) Urinalysis macro (dipstick) panel - Urine
295
2435
1.65
5.55
4.8
4.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
91
555
1.81
5.53
2.0
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
80
469
1.86
5.51
2.7
2.2
%
21.1
23.4
0.78
72
401
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
216
1662
1.59
5.38
4.2
4.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
169
1227
1.61
5.36
3.8
3.5
e6/l
63.7
65.9
0.03
115
873
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
320
2717
1.66
5.18
5.2
3.8
pmol/l
15.0
14.8
0.66
298
2463
(3044640) Blood type and Crossmatch panel - Blood
156
1123
1.60
5.07
2.6
2.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
42
201
2.21
5.06
3.8
3.3
mmol/l
1.6
2.0
0.39
36
153
(3000991) Gas panel - Venous blood
53
278
2.03
5.05
8.1
8.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
237
1884
1.56
4.99
7.9
6.3
umol/l
11.7
11.1
0.38
225
1782
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
397
3603
2.09
4.94
20.6
13.7
mg/l
22.8
22.9
0.02
339
2820
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
24
89
2.79
4.93
1.8
1.6
iu/l
13.2
7.6
—
8
29
(36304419) Bacteria [Presence] in Urine
134
939
1.62
4.83
3.4
2.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
183
1381
1.56
4.80
2.2
2.0
pmol/l
98.6
94.9
0.54
89
691
(3030467) Casts [#/volume] in Urine by Automated count
137
968
1.60
4.76
3.4
2.9
e6/l
0.3
0.4
0.25
101
726
(3009343) pH of Capillary blood
43
213
2.13
4.76
3.8
3.2
ph
7.4
7.4
—
7
26
(3007853) Bacteria identified in Skin by Aerobe culture
70
413
1.83
4.71
2.0
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
43
215
2.11
4.65
3.8
3.2
kpa
5.3
5.2
0.46
43
199
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
187
1429
1.54
4.58
2.5
2.3
nmol/l
78.6
76.9
0.38
171
1281
(40761511) CBC panel - Blood by Automated count
407
3752
2.20
4.47
17.8
12.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
145
1053
1.56
4.43
3.4
3.0
e6/l
27.3
135.3
1.03
109
811
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
26
4.31
4.38
1.1
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
11
26
4.31
4.38
1.1
1.0
u/l
1.2
1.2
—
6
16
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
139
1005
1.56
4.32
2.7
3.0
ng/l
1179.4
1217.3
0.05
118
856
(3021879) Hepatitis B virus core Ab [Presence] in Serum
50
272
1.95
4.31
1.6
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
66
393
1.80
4.31
1.9
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
178
1360
1.52
4.29
3.9
3.5
ng/l
27.2
39.6
1.13
130
949
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
36
3.69
4.23
1.3
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
104
706
1.62
4.20
2.8
2.5
e6/l
6.2
4.7
0.72
85
624
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
66
398
1.78
4.13
1.9
1.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
77
487
1.71
4.08
1.5
1.3
titre
273.3
465.1
1.64
18
102
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
152
1137
1.52
3.99
2.8
2.5
u/l
51.5
55.9
0.80
140
1054
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
33
3.71
3.95
1.4
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
193
1519
1.48
3.95
3.1
2.6
ug/l
117.6
125.8
0.26
180
1410
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
162
1239
1.49
3.78
3.6
3.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
92
621
1.61
3.78
1.8
1.7
nmol/l
1117.3
1208.4
0.52
76
466
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
375
3405
1.70
3.77
18.4
12.6
ml/min/173m2
83.3
81.8
0.70
327
2796
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
117
838
1.54
3.72
2.4
2.0
mg/l
2.9
3.1
0.25
104
719
(3022313) Gas panel - Capillary blood
32
156
2.13
3.72
4.3
3.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
38
198
2.01
3.71
1.7
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
157
1199
1.48
3.67
4.1
3.4
u/l
42.8
31.9
1.06
152
1139
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
60
366
1.74
3.61
3.4
4.3
ug/l
3.0
19.4
0.80
47
302
(3021589) Normoblasts [#/volume] in Blood
198
1586
1.45
3.61
11.0
9.2
e9/l
0.0
0.0
0.16
163
1309
(3022806) Fractional oxyhemoglobin in Capillary blood
14
46
3.11
3.56
1.6
1.7
%
90.0
89.7
0.09
14
46
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
36
187
2.01
3.55
6.3
12.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
178
1401
1.46
3.54
2.2
2.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
87
589
1.60
3.52
2.9
2.6
e6/l
0.9
0.9
0.06
52
334
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
41
3.24
3.52
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
41
3.24
3.52
1.4
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
283
2433
1.46
3.49
4.3
3.2
u/l
45.1
49.2
0.68
261
2281
(3028626) Oxygen [Partial pressure] in Capillary blood
20
82
2.51
3.43
2.3
2.6
kpa
8.0
8.1
0.01
20
73
(3012501) Base excess in Blood by calculation
19
76
2.57
3.42
2.7
2.6
mmol/l
2.3
2.7
0.28
12
52
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
24
108
2.29
3.38
2.6
2.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
75
495
1.62
3.36
1.3
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
25
115
2.24
3.35
2.0
2.0
ug/l
161.0
289.9
1.06
25
109
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
59
367
1.70
3.32
4.7
4.1
u/l
281.5
246.8
0.43
59
346
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
81
549
1.58
3.26
3.0
2.8
e6/l
3.6
2.2
0.34
45
296
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
66
2.64
3.25
1.5
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
33
3.39
3.21
1.5
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
112
821
1.49
3.15
1.6
1.5
nmol/l
20.6
20.9
0.08
98
709
(3026782) Osmolality of Urine
96
686
1.51
3.04
2.7
2.6
mosm/kgh2o
593.9
558.0
0.74
77
583
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
53
329
1.70
3.01
2.8
2.5
g/l
0.2
0.2
0.93
48
308
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
5
10.09
2.98
1.2
1.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
19
82
2.38
2.95
2.1
3.2
umol/l
25.9
36.0
1.42
14
70
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
89
635
1.50
2.83
1.3
1.3
iu/ml
13.4
38.5
4.85
29
201
(3044290) Cell count panel - Cerebral spinal fluid
18
78
2.36
2.78
1.6
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
40
235
1.77
2.76
1.6
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
6
8.41
2.75
6.4
4.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
104
770
1.46
2.75
1.8
1.7
mg/l
3.1
1.2
0.53
80
605
(3026493) Urate [Moles/volume] in Serum or Plasma
124
949
1.43
2.75
3.1
2.5
umol/l
3756.7
7765.0
0.52
104
811
(3052851) Hemolysis interference index of Serum or Plasma
22
106
2.13
2.67
2.3
3.0
—
—
—
0
0
(3019225) pH of Specimen
50
316
1.66
2.67
6.4
4.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
23
113
2.09
2.67
2.0
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
26
134
2.00
2.66
4.7
3.7
mmol/l
25.3
25.2
0.04
26
126
(3000492) Spirometry study
54
349
1.62
2.64
1.7
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
361
3320
1.50
2.64
21.1
14.5
%
39.0
40.2
1.31
267
2423
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
83
592
1.50
2.64
1.3
1.3
u/ml
3.8
10.6
1.47
20
242
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
15
4.72
2.60
1.7
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
366
3380
1.50
2.58
6.3
5.7
mmol/mol
40.0
39.8
0.20
342
3155
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
20
4.05
2.58
3.3
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
38
225
1.75
2.57
3.7
6.8
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
7
7.21
2.55
1.2
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
420
4019
2.10
2.53
28.9
20.0
e9/l
251.5
249.2
0.30
413
3911
(3011397) Hemoglobin [Presence] in Urine by Test strip
107
809
1.43
2.52
3.6
3.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
420
4020
2.09
2.51
28.9
20.0
e12/l
4.5
4.5
0.52
412
3901
(3021447) Carbon dioxide [Partial pressure] in Venous blood
50
322
1.62
2.49
4.0
3.6
kpa
5.8
5.8
0.04
50
314
(3010813) Leukocytes [#/volume] in Blood
420
4021
2.08
2.49
28.9
20.1
e9/l
6.9
6.6
2.30
413
3903
(3021901) Oxygen saturation in Capillary blood
15
63
2.43
2.49
2.5
2.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
16
4.43
2.48
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
51
2.60
2.46
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
23
117
2.02
2.45
1.9
1.7
—
—
—
0
0
(4010399)
42
261
1.67
2.40
1.5
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
377
3516
1.52
2.39
5.1
4.5
mmol/l
5.9
6.0
0.34
345
3225
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
22
3.68
2.37
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
98
2.09
2.35
2.9
2.5
u/ml
0.4
0.4
0.01
11
56
(3025941) Bacteria identified in Stool by Culture
33
193
1.77
2.34
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
407
3868
1.74
2.33
14.3
10.3
u/l
27.9
26.5
0.52
395
3732
(3002032) Base excess in Venous blood by calculation
49
320
1.60
2.32
4.1
3.6
mmol/l
1.5
1.9
0.38
43
256
(3026008) Bacteria identified in Urine by Culture
129
1021
1.37
2.31
3.4
2.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
96
724
1.42
2.28
1.8
1.7
pmol/l
433.1
442.0
0.11
80
608
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
54
363
1.56
2.26
3.8
3.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
38
235
1.68
2.22
1.2
1.2
iu/ml
182.6
148.3
0.13
16
102
(3015235) Bicarbonate [Moles/volume] in Capillary blood
18
87
2.11
2.20
2.9
2.5
mmol/l
25.2
25.2
0.00
18
75
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
62
433
1.50
2.19
5.3
4.5
%
31.8
32.2
0.12
42
286
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
24
3.38
2.19
1.1
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
30
3.04
2.16
1.8
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
49
2.49
2.12
1.1
1.1
—
—
—
0
0
(3036489) Thrombin time
23
124
1.90
2.11
2.2
1.8
s
24.7
21.4
0.85
23
116
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
89
2.07
2.09
2.2
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
62
438
1.48
2.08
1.7
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
10
5.04
2.07
1.2
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
20
3.54
2.06
12.3
7.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
15
4.04
2.04
1.2
1.7
—
—
—
0
0
(3013512) EKG study
128
1030
1.34
2.04
4.3
3.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
126
1.87
2.02
2.2
1.9
—
—
—
0
0
(4027681)
8
26
3.11
2.02
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
26
3.11
2.02
1.1
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
5
11
4.58
1.94
1.2
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
45
2.48
1.94
4.0
2.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
39
2.60
1.93
1.7
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
39
2.60
1.93
1.2
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
71
523
1.43
1.92
2.6
2.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
22
3.22
1.88
1.3
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
42
279
1.56
1.88
3.5
2.6
kpa
4.6
4.5
0.11
42
269
(3044889) 12 lead EKG panel
281
2537
1.30
1.87
4.4
3.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
34
2.68
1.87
2.6
2.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
11
46
2.43
1.86
2.7
3.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
17
3.56
1.84
2.2
2.7
u/ml
593.5
715.4
—
6
17
(1616796) Gas panel - Central venous blood
14
66
2.16
1.84
2.9
2.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
29
2.79
1.80
1.4
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
205
1785
1.28
1.79
3.8
3.5
estimate
0.0
0.0
0.00
33
322
(4094501)
18
95
1.93
1.78
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
101
800
1.34
1.77
1.3
1.2
u/ml
6.8
1.9
0.39
22
235
(3008401) Mugwort IgE Ab [Units/volume] in Serum
10
41
2.47
1.76
1.1
1.0
u/ml
0.1
4.5
—
5
14
(3017143) Hepatitis C virus Ab [Presence] in Serum
57
410
1.45
1.76
2.0
1.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
18
3.36
1.75
1.2
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
57
411
1.44
1.74
4.8
2.9
umol/l
9.8
7.8
0.32
49
363
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
7
24
2.95
1.73
1.6
1.2
u/l
438.0
354.3
—
7
24
(3012516) Albumin [Mass/volume] in Urine
125
1025
1.31
1.72
3.1
3.3
mg/l
559.2
303.2
0.20
80
654
(3006462) Nitrate [Presence] in Urine
5
13
3.88
1.72
3.4
4.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
82
634
1.36
1.68
3.3
2.8
mmol/l
2.4
2.4
0.14
76
559
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
19
3.19
1.66
1.2
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
69
2.06
1.66
1.8
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
69
2.06
1.66
1.5
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
25
2.83
1.65
1.6
2.5
—
—
—
0
0
(4035726)
44
305
1.49
1.64
1.5
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
384
3659
1.40
1.53
5.5
4.9
mmol/l
2.7
2.8
1.31
350
3370
(3022145) Colonoscopy Study observation
56
413
1.41
1.53
1.2
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
378
3593
1.38
1.53
5.0
4.4
mmol/l
4.6
4.7
1.11
345
3334
(3006653) Thiamine [Moles/volume] in Blood
5
15
3.36
1.52
1.0
1.1
nmol/l
161.7
137.9
—
5
15
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
15
3.36
1.52
1.2
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
15
3.36
1.52
1.2
1.8
—
—
—
0
0
(4211845)
5
15
3.36
1.52
3.4
3.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
200
1761
1.25
1.52
5.2
4.8
estimate
0.0
0.0
0.00
35
334
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
72
1.98
1.50
2.0
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
315
0.59
1.49
1.9
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
78
611
1.34
1.48
2.2
1.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
38
2.40
1.46
1.0
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
66
505
1.36
1.45
1.9
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
199
1759
1.24
1.44
3.7
3.5
estimate
0.0
0.0
0.00
35
332
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
41
289
1.46
1.43
1.8
2.3
ug/l
6.0
8.3
0.39
31
263
(3020682) Albumin/Creatinine [Ratio] in Urine
129
1086
1.27
1.43
3.9
4.0
mg/mmol
10.1
7.1
0.28
79
674
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
46
2.20
1.41
1.2
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
38
265
1.48
1.40
1.1
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
29
2.44
1.39
1.1
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
29
2.44
1.39
2.4
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
57
429
1.38
1.39
2.4
2.3
ug/g
83.5
128.8
1.41
41
341
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
60
2.03
1.39
2.2
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
80
635
1.32
1.39
1.6
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
130
1100
1.26
1.38
3.0
3.1
mmol/l
7.8
7.7
0.06
100
910
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
15
83
1.84
1.33
1.3
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
34
2.38
1.29
1.3
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
27
178
1.55
1.29
3.2
2.4
%
1.1
1.3
0.59
27
178
(3002256) Pathology report gross observation
57
435
1.36
1.29
1.4
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
5
18
2.80
1.29
1.0
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
137
1176
1.24
1.27
4.2
4.5
ug/l
1.8
2.4
1.00
119
1061
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
215
0.55
1.27
1.7
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
36
2.24
1.25
1.8
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
45
2.02
1.24
2.1
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
56
1.99
1.23
2.2
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
363
3457
1.29
1.22
4.5
4.0
mmol/l
1.3
1.3
0.24
331
3177
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
37
2.18
1.22
2.5
2.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
246
2249
1.21
1.21
3.2
3.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
101
1.71
1.21
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
141
1.59
1.19
2.2
2.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
118
1.64
1.17
1.6
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
21
134
1.60
1.16
1.3
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
39
2.07
1.16
1.6
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
20
2.52
1.15
1.4
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
18
111
1.65
1.14
1.5
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
40
2.02
1.12
3.1
3.2
nmol/l
4.5
3.3
—
8
40
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
51
1.98
1.12
2.4
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
18
112
1.63
1.10
1.7
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
32
2.21
1.08
1.7
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
59
466
1.31
1.08
2.2
1.7
%
1.8
1.4
1.35
53
409
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
97
1.67
1.08
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
33
2.14
1.06
1.7
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
98
1.66
1.04
1.9
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
29
205
1.44
1.04
1.6
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
75
1.76
1.04
1.3
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
22
2.29
1.03
1.2
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
5
22
2.29
1.03
1.0
1.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
7
34
2.08
1.03
1.3
1.2
nmol/l
413.6
381.0
—
7
28
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
372
3573
1.27
1.03
5.1
4.4
mmol/l
1.5
1.5
0.17
338
3299
(3047181) Lactate [Moles/volume] in Blood
17
107
1.61
1.01
5.5
11.0
mmol/l
1.1
1.2
0.18
17
96
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
135
0.51
1.00
1.4
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
61
1.82
0.99
3.3
3.7
%
60.5
59.2
0.18
11
61
(3009214) Lutropin [Units/volume] in Serum or Plasma
16
100
1.62
0.98
1.3
1.2
u/l
8.9
9.5
—
9
79
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
16
100
1.62
0.98
1.6
2.2
mg/l
11.1
11.4
0.04
16
94
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
17
108
1.60
0.98
2.6
1.8
%
83.6
89.2
0.36
17
103
(3011288) Drugs identified in Urine by Screen method
13
77
1.71
0.96
1.7
1.8
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
13
77
1.71
0.96
6.2
13.1
mmol/l
104.6
105.3
0.14
13
70
(3039000) Anion gap in Blood
13
77
1.71
0.96
6.1
13.1
mmol/l
13.2
10.8
0.42
13
70
(21494434) Karyotype in Bone marrow
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
52
1.75
0.93
2.4
2.9
—
1121.2
—
0
6
(3028026) IgM [Mass/volume] in Serum or Plasma
32
236
1.38
0.93
1.9
1.6
g/l
1.2
1.4
0.47
27
216
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
37
280
1.35
0.92
3.0
2.7
ml/min/173m2
66.2
66.0
0.01
18
120
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
42
1.92
0.89
1.1
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
42
1.92
0.89
1.6
1.3
nmol/l
0.6
0.5
—
8
37
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
95
1.60
0.88
1.9
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
95
1.60
0.88
1.1
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
43
1.88
0.87
1.5
3.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
128
1.51
0.87
1.9
1.8
—
—
—
0
0
(4146454)
6
30
2.01
0.87
2.0
2.9
—
—
—
0
0
(4024509)
6
30
2.01
0.87
2.3
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
44
1.83
0.86
1.8
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
65
1.71
0.83
2.8
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
32
1.89
0.82
3.2
2.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
48
385
1.28
0.81
1.6
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
190
1.39
0.81
1.1
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
58
1.74
0.80
2.1
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
106
1.53
0.80
1.0
1.4
ug/g
456.2
280.5
—
5
60
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
25
182
1.40
0.80
2.5
2.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
23
166
1.41
0.77
1.3
1.8
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
34
1.78
0.76
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
34
1.78
0.76
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
34
1.78
0.76
1.3
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
59
1.71
0.76
3.0
3.3
e9/l
4.0
4.7
—
10
59
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
67
1.66
0.75
3.0
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
75
1.62
0.75
2.6
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
108
1.50
0.74
1.3
1.6
—
—
—
0
0
(4062490)
7
38
1.86
0.74
1.1
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
38
300
1.29
0.74
3.9
3.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
100
1.52
0.73
1.7
2.4
u/l
3312.7
2727.0
—
5
34
(3021788) Differential panel - Synovial fluid
9
56
1.62
0.72
1.2
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
68
1.63
0.72
2.0
1.7
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
40
1.76
0.71
1.1
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
26
1.93
0.71
1.8
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
9
58
1.56
0.70
4.9
3.2
nmol/l
0.7
0.7
—
9
48
(3013139) Helicobacter pylori Ag [Presence] in Stool
32
249
1.31
0.69
1.1
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
59
1.54
0.68
1.3
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
35
280
1.27
0.63
3.0
2.6
e9/l
70.2
71.3
0.06
23
212
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
52
436
1.22
0.63
7.6
6.5
—
—
—
0
0
(3020891) Body temperature
18
130
1.40
0.62
3.2
4.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
30
1.67
0.61
4.2
1.6
%
8.0
12.0
—
5
30
(3020191) Ethanol [Moles/volume] in Serum or Plasma
5
30
1.67
0.61
1.0
1.3
promille
0.4
1.4
—
5
23
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
50
1.61
0.61
1.1
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
16.2
—
1564.8
—
0
21
(3007930) Methemoglobin/Hemoglobin.total in Blood
19
140
1.37
0.59
5.2
8.7
%
0.9
0.9
0.10
19
132
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
106
952
1.15
0.59
3.5
4.0
%
25.4
21.7
1.31
49
450
(3000764) Benzodiazepines [Presence] in Urine
17
123
1.40
0.58
1.3
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
82
723
1.17
0.58
1.7
1.4
g/l
2.2
2.5
0.76
46
438
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
19
141
1.36
0.57
5.2
8.7
%
1.7
1.6
0.13
19
132
(3028300) Cannabinoids [Presence] in Urine
17
124
1.39
0.56
1.3
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
124
1.39
0.56
1.3
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
55
1.46
0.56
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
55
1.46
0.56
1.3
2.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
107
1.42
0.56
1.1
1.5
miu/ml
155.2
276.0
—
5
49
(3003740) Influenza virus B Ag [Presence] in Specimen
10
65
1.55
0.56
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
65
1.55
0.56
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
28
222
1.28
0.55
2.9
2.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
116
1.39
0.55
1.3
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
12
82
1.48
0.55
4.6
3.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
17
125
1.37
0.54
1.3
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
15
203
0.73
0.53
6.5
2.7
u/ml
26.4
45.6
0.57
15
194
(1761868) Lipid panel - Serum or Plasma
122
1327
0.89
0.50
3.0
2.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
45
1.56
0.49
1.3
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
94
1.39
0.46
1.3
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
69
1.46
0.44
1.2
1.1
—
—
—
0
0
(4034850)
9
129
0.69
0.44
12.3
10.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
96
1.37
0.42
1.4
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
8.9
—
0
15
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.2
—
38.6
—
0
9
(3035933) Granulocytes/100 leukocytes in Blood
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
16
123
1.31
0.41
2.0
3.4
g/l
0.4
0.2
—
6
50
(3023323) Follitropin [Units/volume] in Serum or Plasma
18
141
1.29
0.41
1.3
1.3
iu/l
15.6
27.2
1.33
13
120
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
34
288
1.20
0.40
4.1
3.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
60
1.34
0.40
1.1
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.4
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
90
824
1.12
0.38
4.1
4.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
36
1.39
0.38
2.2
1.6
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
9
68
1.33
0.38
4.2
3.8
u/ml
39.4
26.9
—
9
68
(42529406) Shigella sp [Presence] in Stool by Culture
14
107
1.32
0.37
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
107
1.32
0.37
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
107
1.32
0.37
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
320
0.83
0.36
1.7
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.36
1.3
1.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
79
0.63
0.36
1.0
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
17
135
1.27
0.35
1.1
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
127
1.27
0.34
1.9
2.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
46
1.31
0.33
1.0
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
30
258
1.17
0.32
5.4
3.6
ng/l
72.1
79.8
0.23
30
230
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
37
324
1.16
0.32
2.2
1.9
—
—
—
0
0
(44790047)
7
52
1.35
0.31
1.4
1.5
—
—
—
0
0
(44790048)
7
52
1.35
0.31
1.4
1.5
—
—
—
0
0
(44790049)
7
52
1.35
0.31
1.4
1.5
—
—
—
0
0
(44806118)
7
52
1.35
0.31
1.4
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
19
229
0.82
0.31
1.5
2.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
96
0.72
0.31
1.7
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
33
289
1.15
0.29
2.9
4.4
%
0.1
0.2
—
10
83
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
75
693
1.10
0.28
2.6
2.8
ug/l
0.7
0.8
0.26
44
451
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
103
1.27
0.28
1.6
2.4
ug/min
65.7
66.6
—
8
56
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
94
1.28
0.28
1.2
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
62
1.30
0.28
1.0
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
62
1.30
0.28
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
62
1.30
0.28
1.6
1.4
—
—
—
0
0
(1002224) Polysomnography panel
20
168
1.20
0.27
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
72
1.26
0.26
2.2
2.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
21
179
1.18
0.25
2.2
2.7
e6/l
0.4
0.2
0.72
21
171
(3019832) Treponema pallidum Ab [Presence] in Serum
34
302
1.14
0.25
1.6
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
58
533
1.10
0.25
1.5
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
87
1.27
0.24
1.0
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
31
275
1.14
0.24
3.1
4.4
%
0.0
0.1
—
8
70
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
136
0.80
0.23
2.1
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
40
362
1.12
0.23
2.3
2.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
79
1.27
0.22
1.8
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
41
1.22
0.22
7.8
3.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
41
1.22
0.22
1.4
1.8
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.2
—
105.7
—
0
11
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
10
0.00
0.21
0.0
1.0
—
137.6
—
0
10
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4268621)
5
43
1.16
0.21
1.8
2.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
49
1.23
0.20
1.0
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
49
1.23
0.20
1.0
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
20
174
1.16
0.20
1.0
1.1
—
104.2
—
0
5
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
99
1.22
0.20
1.8
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
52
1.16
0.19
9.7
4.6
umol/l
402.0
340.6
—
6
47
(3035285) Chloride [Moles/volume] in Venous blood
6
53
1.13
0.18
1.3
2.6
mmol/l
107.7
106.2
—
6
53
(3041354) Potassium [Moles/volume] in Venous blood
6
53
1.13
0.18
1.3
2.6
mmol/l
4.0
4.0
—
6
53
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
53
1.13
0.18
1.3
2.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
103
985
1.06
0.18
1.8
1.7
mmol/l
1.3
1.4
0.57
85
844
(3000330) Specific gravity of Urine by Test strip
20
177
1.14
0.16
3.4
3.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
80
0.75
0.15
1.3
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
80
0.75
0.15
1.3
4.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
34
313
1.09
0.15
3.0
4.2
%
0.7
0.9
—
10
96
(3034860) Kappa light chains.free [Mass/volume] in Serum
9
107
0.84
0.13
1.9
4.1
mg/l
33.3
98.7
—
9
84
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
9
107
0.84
0.13
1.9
4.1
mg/l
26.7
31.8
—
9
85
(3019150) Specific gravity of Urine by Refractometry
82
787
1.05
0.13
4.1
3.7
kg/l
1.0
1.0
0.01
14
111
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
171
1.12
0.12
3.2
2.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
147
0.88
0.11
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
19
172
1.11
0.11
1.2
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
103
998
1.04
0.11
1.4
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
14
124
1.13
0.11
1.6
1.4
g/l
0.2
0.2
0.03
14
118
(21494755) Public health laboratory ask at order entry panel
38
358
1.07
0.11
1.5
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
44
1.14
0.10
1.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
48
1.04
0.09
1.0
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
14
126
1.11
0.09
3.4
2.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
57
1.05
0.08
1.3
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
61
0.82
0.08
1.2
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
63
0.79
0.08
1.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
63
0.79
0.08
1.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
65
0.77
0.08
1.0
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
64
1.10
0.08
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
71
0.84
0.07
1.0
1.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
75
0.80
0.07
1.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
75
0.80
0.07
1.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
75
0.80
0.07
1.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
75
0.80
0.07
1.0
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
7
80
0.87
0.07
1.7
1.8
pmol/l
245.3
236.8
—
7
74
(3050129) First trimester maternal screen panel - Serum or Plasma
8
92
0.87
0.07
1.1
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
103
0.87
0.06
3.9
4.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
9
105
0.85
0.06
1.9
4.0
—
2.2
—
0
16
(3029937) Albumin [Presence] in Urine by Test strip
92
937
0.98
0.05
4.5
3.7
estimate
0.0
0.0
0.00
34
327
(3002179) Metamyelocytes/100 leukocytes in Blood
29
279
1.04
0.04
3.2
4.3
%
0.1
0.4
—
7
62
(3017732) Neutrophils [#/volume] in Blood
26
250
1.04
0.03
2.8
2.6
e9/l
4.1
4.1
0.02
21
199
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
92
1.09
0.03
1.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
101
998
1.02
0.03
3.2
3.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
140
1390
1.01
0.02
4.1
3.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
106
0.94
0.01
1.6
1.4
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
1.8
—
1.2
—
0
9
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
49
1.02
0.00
1.0
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
49
1.02
0.00
1.0
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
49
1.02
0.00
1.0
1.4
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
8
0.00
0.00
0.0
2.1
—
278.4
—
0
8
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
1.9
—
1.3
—
0
8
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4306422)
5
53
0.94
0.00
1.0
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
28.1
—
0
7
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
50
1.00
0.00
1.0
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
40.8
—
0
5
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
64
0.94
0.00
1.3
1.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_HORNER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HORNER | 1.65 [1.36, 2.0] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.712 |
During the follow-up period (1.1.1998 — 31.12.2019), 199 out of 1204 females with G6_HORNER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HORNER | 1.362 [1.12, 1.65] | 0.002 |
| Birth year | 0.988 [0.98, 1.0] | 0.016 |
During the follow-up period (1.1.1998 — 31.12.2019), 172 out of 1188 males with G6_HORNER died.
Mortality risk
Mortality risk for people of age
years, who have G6_HORNER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.154% | 0.27% |
| 5 | 0.995% | 1.74% |
| 10 | 2.61% | 4.415% |
| 15 | 5.056% | 8.223% |
| 20 | 9.002% | 13.224% |
Relationships between endpoints
↥Index endpoint: G6_HORNER – Horner syndrome
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data